• Bristol Myers Squibb will expand its AI collaboration with NVIDIA by deploying an NVIDIA DGX SuperPOD using DGX Vera Rubin NVL72 systems.
• The buildout is set to become the most powerful, energy-efficient single-owner NVIDIA compute infrastructure in life sciences.
• Vera Rubin is expected to deliver up to 10x higher performance per megawatt than the prior architecture, supporting larger AI workloads.
• The cluster will underpin new foundation models trained on proprietary data, using NVIDIA’s BioNeMo platform for biological AI where needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bristol-Myers Squibb Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20260720065516) on July 20, 2026, and is solely responsible for the information contained therein.